Skip to main content
VCbacked
Log inGet Started

Tentarix Biotherapeutics

San Diego, United States

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

$35.0M raised
Sep 2023
Series B
BiotechnologyLife ScienceMedical

Top Investors

Samsara BioCapitalVersant VenturesGilead SciencesAmplitude Venture Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tentarix Biotherapeutics

How much funding has Tentarix Biotherapeutics raised?
Tentarix Biotherapeutics has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in September 2023.
Who are Tentarix Biotherapeutics's investors?
Tentarix Biotherapeutics's investors include Samsara BioCapital, Versant Ventures, Gilead Sciences, Amplitude Venture Capital.
Where is Tentarix Biotherapeutics headquartered?
Tentarix Biotherapeutics is headquartered in San Diego, United States.
What does Tentarix Biotherapeutics do?
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
What stage is Tentarix Biotherapeutics at?
Tentarix Biotherapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Tentarix Biotherapeutics — Funding & Investors." VCBacked, September 6, 2023, https://www.vcbacked.co/company/tentarix-biotherapeutics. Accessed June 17, 2026.
APA
VCBacked. (2023). Tentarix Biotherapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/tentarix-biotherapeutics
Wikipedia (cite web)
{{cite web |title=Tentarix Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tentarix-biotherapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong